- Home
- DOV vs BNTX Comparison
DOV vs BNTX Comparison
Compare DOV & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DOV | BNTX |
|---|---|---|
| Founded | 1947 | 2008 |
| Country | United States | Germany |
| Employees | N/A | 7807 |
| Industry | Industrial Machinery/Components | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 31.5B | 22.8B |
| IPO Year | 1994 | 2019 |
Fundamental Metrics
Financial Performance| Metric | DOV | BNTX |
|---|---|---|
| Price | $211.75 | $90.20 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 10 | 13 |
| Target Price | ★ $225.20 | $134.15 |
| AVG Volume (30 Days) | 1.1M | ★ 1.1M |
| Earning Date | 04-23-2026 | 03-10-2026 |
| Dividend Yield | ★ 0.98% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 7.94 | N/A |
| Revenue | ★ $6,992,118,000.00 | N/A |
| Revenue This Year | $6.95 | N/A |
| Revenue Next Year | $4.40 | $2.61 |
| P/E Ratio | $26.69 | ★ N/A |
| Revenue Growth | ★ 2.51 | N/A |
| 52 Week Low | $143.04 | $79.81 |
| 52 Week High | $237.54 | $124.00 |
Technical Indicators
Market Signals| Indicator | DOV | BNTX |
|---|---|---|
| Relative Strength Index (RSI) | 45.39 | 37.17 |
| Support Level | $197.41 | $79.81 |
| Resistance Level | $237.54 | $112.30 |
| Average True Range (ATR) | 4.95 | 3.59 |
| MACD | -1.41 | -1.11 |
| Stochastic Oscillator | 40.60 | 32.54 |
Price Performance
Historical ComparisonAbout DOV Dover Corporation
Founded in 1955 by George Ohrstrom, Dover has become an industrial behemoth through the acquisition of dozens of esteemed brands. The company is organized into five segments through which it designs and manufactures highly engineered components, such as vehicle repair, factory automation, welding, aerospace, fuel dispensing, printing, liquid handling, refrigeration, and can-making equipment. It has operations around the globe but generates over half of its revenue in the United States.
About BNTX BioNTech SE
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens and neoantigens; monospecific and bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.